Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Recipharm AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Recipharm AB, Medical Devices Deals, 2012 to YTD 2018 12
Recipharm AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Recipharm AB, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Recipharm Acquires CMO Business from Sanofi for USD60.2 Million 15
Recipharm Acquires Manufacturing Facility from Roche 17
Recipharm Acquires Development and Manufacturing Facility from Flamel for USD13.2 Million 18
Partnerships 20
Kancera and Recipharm Enter into Partnership 20
Klaria Pharma Partners with Recipharm and Clinical Trial Consultants 21
Recipharm Enters into Agreement with Follicum 22
Recipharm Enters into Agreement with Synthonics 23
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 24
Recipharm Enters Into Co-Promotion Agreement With Synthonics 25
Licensing Agreements 26
Recipharm Enters into Licensing Agreement with Altus Formulation 26
Alitair Pharma And Edmond Pharma Enter Into Licensing Agreement For Erdosteine 27
Equity Offering 28
Recipharm Raises USD58.7 Million in Public Offering of Share 28
Recipharm Raises USD99 Million in Rights Offering of Shares 30
Recipharm to Raise USD15.5 Million in Private Placement of Class B Shares 32
Recipharm Raises USD32 Million in Private Placement of Shares 33
Synthonics Raises USD2 Million in Private Placement of Preferred Shares 34
Flamel to Raise USD13.1 Million in Private Placement of Shares 35
Recipharm Announces Underwriters Exercise Of Over-Allotment Option Of IPO For US$131.37 Million 36
Debt Offering 38
Recipharm Raises USD116.4 Million in Private Placement of Bonds 38
Asset Transactions 39
Serb Acquires Rights for ThyroSafe from Recipharm for USD11.1 Million 39
Acquisition 40
Recipharm Acquires Remaining 26% Stake in Nitin Lifesciences for USD43.8 Million 40
Recipharm Acquires Kemwell Biopharma for USD120 Million 41
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 42
Recipharm Acquires 74% Stake in Nitin Lifesciences for USD101 Million 44
Recipharm Italia Acquires Mitim for USD75 Million 46
Recipharm Acquires Kaysersberg Pharma from Alcon for USD16.6 Million 47
Recipharm Acquires OnTarget Chemistry for USD1.8 Million 48
Recipharm Acquires Lusomedicameta Sociedade for USD135 Million 49
Recipharm Acquires Corvette Pharma Services from LBO Italia Investimenti for USD160 Million 50
Kemwell Biopharma Acquires Cirrus Pharma 51
Recipharm AB – Key Competitors 52
Recipharm AB – Key Employees 53
Recipharm AB – Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 58
Strategy And Business Planning 58
May 24, 2018: Recipharm invests in Brexit preparations 58
Nov 09, 2017: Recipharm to end operations in two facilities in Sweden 59
Apr 24, 2017: Recipharm opens new GMP suite for clinical trial material 60
Financial Announcements 61
Jul 25, 2018: Recipharm publishes its interim report January-June 2018 61
Feb 22, 2018: Recipharm Reports Fourth Quarter And Full Year 2017 62
Nov 09, 2017: Recipharm: Interim report January – September 2017 64
Jul 25, 2017: Recipharm: Interim report January – June 2017 66
Apr 27, 2017: Recipharm: Interim report January-March 2017 67
Feb 23, 2017: Recipharm: Full Year report January – December 2016 68
Corporate Communications 72
Oct 03, 2018: Recipharm names Tobias Hagglov as Chief Financial Officer 72
May 09, 2018: Recipharm appoints new Chief Financial Officer 73
Feb 26, 2018: Recipharm: Chief Financial Officer to leave Recipharm 74
Feb 14, 2018: Recipharm Appoints President Development Services to Drive End to End Offering 75
Apr 11, 2017: Recipharm appoints Henrik Stenqvist as new Chief Financial Officer 76
Legal and Regulatory 77
Oct 25, 2018: Manufacturing licence restriction at Recipharm, Ashton-u-Lyne, UK facility 77
Sep 13, 2018: Recipharm connects to European Hub for serialisation compliance 78
Product News 79
Oct 09, 2018: Recipharm releases first serialised products to Europe 79
Other Significant Developments 80
Oct 19, 2018: Recipharm continues manufacturing operations in Hoganas, Sweden 80
Jul 02, 2018: Recipharm launches standalone serialisation service 81
Mar 14, 2018: Recipharm completes Blow-fill-seal expansion at Kaysersberg facility 82
Nov 27, 2017: Recipharm equips a further three facilities for US serialisation 83
Oct 23, 2017: Recipharm equips Lisbon facility for US and European serialisation 84
Apr 21, 2017: Recipharm delivers first serialised batch to Saudi Arabia 85
Appendix 86
Methodology 86
About GlobalData 86
Contact Us 86
Disclaimer 86
Recipharm AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Recipharm AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Recipharm AB, Deals By Therapy Area, 2012 to YTD 2018 10
Recipharm AB, Medical Devices Deals, 2012 to YTD 2018 12
Recipharm AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Recipharm Acquires CMO Business from Sanofi for USD60.2 Million 15
Recipharm Acquires Manufacturing Facility from Roche 17
Recipharm Acquires Development and Manufacturing Facility from Flamel for USD13.2 Million 18
Kancera and Recipharm Enter into Partnership 20
Klaria Pharma Partners with Recipharm and Clinical Trial Consultants 21
Recipharm Enters into Agreement with Follicum 22
Recipharm Enters into Agreement with Synthonics 23
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 24
Recipharm Enters Into Co-Promotion Agreement With Synthonics 25
Recipharm Enters into Licensing Agreement with Altus Formulation 26
Alitair Pharma And Edmond Pharma Enter Into Licensing Agreement For Erdosteine 27
Recipharm Raises USD58.7 Million in Public Offering of Share 28
Recipharm Raises USD99 Million in Rights Offering of Shares 30
Recipharm to Raise USD15.5 Million in Private Placement of Class B Shares 32
Recipharm Raises USD32 Million in Private Placement of Shares 33
Synthonics Raises USD2 Million in Private Placement of Preferred Shares 34
Flamel to Raise USD13.1 Million in Private Placement of Shares 35
Recipharm Announces Underwriters Exercise Of Over-Allotment Option Of IPO For US$131.37 Million 36
Recipharm Raises USD116.4 Million in Private Placement of Bonds 38
Serb Acquires Rights for ThyroSafe from Recipharm for USD11.1 Million 39
Recipharm Acquires Remaining 26% Stake in Nitin Lifesciences for USD43.8 Million 40
Recipharm Acquires Kemwell Biopharma for USD120 Million 41
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 42
Recipharm Acquires 74% Stake in Nitin Lifesciences for USD101 Million 44
Recipharm Italia Acquires Mitim for USD75 Million 46
Recipharm Acquires Kaysersberg Pharma from Alcon for USD16.6 Million 47
Recipharm Acquires OnTarget Chemistry for USD1.8 Million 48
Recipharm Acquires Lusomedicameta Sociedade for USD135 Million 49
Recipharm Acquires Corvette Pharma Services from LBO Italia Investimenti for USD160 Million 50
Kemwell Biopharma Acquires Cirrus Pharma 51
Recipharm AB, Key Competitors 52
Recipharm AB, Key Employees 53
Recipharm AB, Other Locations 55
Recipharm AB, Subsidiaries 55
List of Figures
Recipharm AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Recipharm AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Recipharm AB, Medical Devices Deals, 2012 to YTD 2018 12